Dairy protein and leucine alter GLP-1 release and mRNA of genes involved in intestinal lipid metabolism in vitro - PubMed (original) (raw)

Dairy protein and leucine alter GLP-1 release and mRNA of genes involved in intestinal lipid metabolism in vitro

Qixuan Chen et al. Nutrition. 2009 Mar.

Abstract

Objective: A growing body of evidence supports an antiobesity effect of dairy products; however, the mechanisms remain unclear. The objective of this study was to explore possible intestinal mechanisms by which dairy delivers an antiobesity effect. The human intestinal cell line, NCI-H716, was used to test the hypothesis that branched-chain amino acids and dairy proteins regulate satiety hormone secretion and modulate genes involved in fatty acid and cholesterol metabolism.

Methods: In dose-response (0.5%, 1.0%, 2.0%, and 3.0%) studies, the effect of leucine, isoleucine, valine, skim milk, casein, and whey on glucagon-like peptide-1 release and the expression of selected genes were tested.

Results: Leucine, isoleucine, skim milk, and casein stimulated glucagon-like peptide-1 release (P < 0.05). Isoleucine and whey downregulated the expression of intestinal-type fatty acid binding protein (i-FABP), fatty acid transport protein 4 (FATP4), Niemann-Pick C-1-like-1 protein (NPC1L1), acetyl-coenzyme A carboxylase (ACC), fatty acid synthase (FAS), sterol regulatory element-binding protein-2 (SREBP-2), and 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR; P < 0.05). Leucine and valine downregulated the expression of NPC1L1, ACC, FAS, SREBP-2, and HMGCR (P < 0.05). Casein downregulated the expression of i-FABP, FATP4, ACC, FAS, SREBP-2, and HMGCR (P < 0.05). Skim milk downregulated the expression of ACC, FAS, and SREBP-2, but not i-FABP, FATP4, and NPC1L1.

Conclusion: This work suggests that the antiobesity effect of dairy may be mediated, at least in part, by integration of events that promote glucagon-like peptide-1 secretion and inhibit expression of genes involved in intestinal fatty acid and cholesterol absorption and synthesis.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Effects of branched-chain amino acids, skim milk, casein, and whey on GLP-1 release in NCI-H716 cells. Cells (1 × 106) were incubated for 2 h with increasing concentrations of (A) leucine, isoleucine, valine and (B) skim milk, casein, and whey. Secretion into the medium was normalized to the total cellular content and expressed as a percentage of the control value. Due to lower solubility, leucine concentrations were 1.5% and 2.0% instead of 2.0% and 3.0%. Values are means ± SEMs of four independent experiments. Treatments with different letters are significantly different (P < 0.05). GLP-1, glucagon-like peptide-1.

Fig. 2

Fig. 2

Effects of leucine, isoleucine, and valine on in vitro mRNA expression of (A) i-FABP, (B) FATP4, and (C) NPC1L1. NCI-H716 cells (2 × 106) were incubated for 42 h with Dulbecco’s Minimal Eagle’s Medium plus 0.2% bovine serum albumin with or without one of the treatments (w/v). Polymerase chain reaction products for genes of interest were normalized to _β_-actin mRNA as a control. Due to lower solubility, leucine concentrations are 1.5% and 2.0% instead of 2.0% and 3.0%. Values are means ± SEMs of four experiments. Treatments with different letters are significantly different (P < 0.05). FATP4, fatty acid transport protein-4; i-FAB, intestinal-type fatty acid binding protein; NPC1L1, Niemann-Pick C-1–like-1 protein.

Fig. 3

Fig. 3

Effect of leucine, isoleucine, and valine on in vitro mRNA expression of (A) ACC, (B) FAS, (C) SREBP-2, and (D) HMGCR. NCI-H716 cells (2 × 106) were incubated for 42 h with Dulbecco’s Minimal Eagle’s Medium plus 0.2% bovine serum albumin with or without one of the treatments (w/v). Due to lower solubility, leucine concentrations are 1.5% and 2.0% instead of 2.0% and 3.0%. Values are means ± SEMs of four experiments. Treatments with different letters are significantly different (P < 0.05). ACC, acetyl-coenzyme A carboxylase; FAS, fatty acid synthase; HMGCR, 3-hydroxy-3-methylglutaryl-coenzyme A reductase; SREBP-2, sterol regulatory element binding protein-2.

Fig. 4

Fig. 4

Effects of skim milk, casein, and whey on in vitro mRNA expression of (A) i-FABP, (B) FATP4, and (C) NPC1L1. NCI-H716 cells (2 × 106) were incubated for 42 h with Dulbecco’s Minimal Eagle’s Medium plus 0.2% bovine serum albumin with or without one of the treatments (w/v). Values are means ± SEMs of four experiments. Treatments with different letters are significantly different (P < 0.05). FATP4, fatty acid transport protein-4; i-FABP, intestinal-type fatty acid binding protein; NPC1L1, Niemann-Pick C-1–like-1 protein.

Fig. 5

Fig. 5

Effects of skim milk, casein, and whey on in vitro mRNA expression of (A) ACC, (B) FAS, (C) SREBP-2, and (D) HMGCR. NCI-H716 cells (2 × 106) were incubated for 42 h with Dulbecco’s Minimal Eagle’s Medium plus 0.2% bovine serum albumin with or without one of the treatments (w/v). Values are means ± SEMs of four experiments. Treatments with different letters are significantly different (P < 0.05). ACC, acetyl-coenzyme A carboxylase; FAS, fatty acid synthase; HMGCR, 3-hydroxy-3-methylglutaryl-cenzyme A reductase; SREBP-2, sterol regulatory element binding protein-2.

Similar articles

Cited by

References

    1. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F. Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr. 2005;82:523–30. - PubMed
    1. Brooks BM, Rajeshwari R, Nicklas TA, Yang SJ, Berenson GS. Association of calcium intake, dairy product consumption with overweight status in young adults (1995–1996): the Bogalusa Heart Study. J Am Coll Nutr. 2006;25:523–32. - PMC - PubMed
    1. Dixon LB, Pellizzon MA, Jawad AF, Tershakovec AM. Calcium and dairy intake and measures of obesity in hyper- and normocholesterolemic children. Obes Res. 2005;13:1727–38. - PubMed
    1. Rajpathak SN, Rimm EB, Rosner B, Willett WC, Hu FB. Calcium and dairy intakes in relation to long-term weight gain in US men. Am J Clin Nutr. 2006;83:559–66. - PubMed
    1. Snijder MB, van der Heijden AA, van Dam RM, Stehouwer CD, Hiddink GJ, Nijpels G, et al. Is higher dairy consumption associated with lower body weight and fewer metabolic disturbances? The Hoorn Study Am J Clin Nutr. 2007;85:989–95. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources